We found in our previous experiments that PPARγ inhibits PAH by targeting SOCE and TRPC1/6, which results in anti-proliferation and pro-apoptosis effects on PASMCs (Wang et al., 2015). The gene discussed is TRPC1; the disease is pulmonary arterial hypertension.